Video Experimental Relacionado
Updated: Jul 3, 2026
15:43
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 18, 2014
Infección por virus sincitial respiratorio infección por virus sincitial respiratorio
1Department of Pediatrics, University of Colorado School of Medicine, and Children's Hospital, Denver 80218, USA.
Lancet (London, England)
|September 15, 1999
Resumen
El virus sincitial respiratorio (VSR) causa enfermedad pulmonar grave en bebés y ancianos. La profilaxis pasiva de anticuerpos es prometedora en la prevención de la enfermedad grave por VSR, impulsando el desarrollo de vacunas.
Área de la Ciencia:
- Virología Virología.
- Inmunología Inmunología.
- Salud Pública La salud pública.
Sus antecedentes:
- El virus sincitial respiratorio (VSR) es una de las principales causas de infecciones del tracto respiratorio inferior en los bebés.
- La infección por RSV también conduce a una enfermedad pulmonar grave en adultos, particularmente en la población anciana.
- Estudios previos demostraron la eficacia de la profilaxis pasiva contra la enfermedad grave por VRS en niños de alto riesgo.
Objetivo del estudio:
- Investigar los mecanismos inmunológicos de protección contra el RSV.
- Explorar el potencial para desarrollar vacunas contra el RSV.
- Comprender el papel del RSV en las enfermedades respiratorias de los adultos.
Principales métodos:
- Revisión de la literatura existente sobre inmunología y profilaxis del VSR.
- Análisis de los datos de la profilaxis pasiva utilizando anticuerpos policlonales y monoclonales.
- Evaluación de las respuestas inmunes en bebés y adultos afectados por el RSV.
Principales resultados:
- La administración pasiva de anticuerpos previene eficazmente la enfermedad pulmonar grave relacionada con el RSV en poblaciones vulnerables.
- La evidencia sugiere un papel importante para el sistema inmunológico en el control de la infección por RSV.
- La eficacia de la profilaxis de anticuerpos apoya una mayor investigación sobre las intervenciones dirigidas.
Conclusiones:
- El RSV representa una amenaza significativa tanto para las poblaciones de bebés como para las de ancianos.
- Las estrategias basadas en el sistema inmunológico, incluida la profilaxis pasiva, son cruciales para controlar la enfermedad grave por VSR.
- El renovado interés en la inmunología del RSV está allanando el camino para el desarrollo de nuevas vacunas.
Videos de Conceptos Relacionados
01:31Respiratory System Abnormal Finding II: Palpation and Auscultation
In assessing respiratory abnormalities, palpation and auscultation are critical tools for detecting and interpreting various pathophysiological changes. These techniques provide insight into underlying disorders by evaluating tactile sensations and sounds produced by the respiratory system.
Palpation Findings
During a respiratory assessment, palpation can reveal several vital abnormalities:
Palpation Findings
During a respiratory assessment, palpation can reveal several vital abnormalities:
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...